Notable Labs, Ltd. (NTBL)
(Delayed Data from NSDQ)
$0.50 USD
+0.01 (1.44%)
Updated Sep 12, 2024 03:42 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Income Statements
Fiscal Year end for Notable Labs, Ltd falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 1 | 1 | 1 | 1 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 1 | 0 | 1 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 15 | 33 | 30 | 25 | 20 |
Income After Depreciation & Amortization | -15 | -33 | -30 | -24 | -20 |
Non-Operating Income | 3 | 1 | 0 | 0 | 1 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -11 | -32 | -30 | -24 | -19 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -11 | -32 | -30 | -24 | -19 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -11 | -32 | -30 | -24 | -19 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -14 | -32 | -29 | -23 | -18 |
Depreciation & Amortization (Cash Flow) | 0 | 1 | 1 | 1 | 2 |
Income After Depreciation & Amortization | -15 | -33 | -30 | -24 | -20 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 3.30 | 2.22 | 1.90 | 1.25 | 1.03 |
Diluted EPS Before Non-Recurring Items | -3.41 | -14.69 | -15.73 | -19.23 | -18.88 |
Diluted Net EPS (GAAP) | -3.41 | -14.69 | -15.73 | -19.23 | -18.88 |
Fiscal Year end for Notable Labs, Ltd falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 0.31 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.20 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | -0.20 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 5.38 | 3.84 | 9.99 | 1.00 | 0.51 |
Income After SG&A, R&D, and Dept/Amort Expenses | -5.38 | -3.84 | -10.19 | -1.00 | -0.51 |
Non-Operating Income | 0.16 | 0.07 | 3.68 | 0.00 | -0.35 |
Interest Expense | 0.00 | 0.00 | -0.09 | 0.06 | 0.01 |
Pretax Income | -5.22 | -3.77 | -6.68 | -1.07 | -0.87 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -5.22 | -3.77 | -6.68 | -1.07 | -0.87 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -5.22 | -3.77 | -6.68 | -1.07 | -0.87 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 9.46 | 9.02 | NA | 2.24 | 2.24 |
Diluted EPS Before Non-Recurring Items | -0.55 | -0.42 | NA | -0.48 | -0.35 |
Diluted Net EPS (GAAP) | -0.55 | -0.42 | -1.53 | -0.48 | -0.35 |